Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation

Infections caused by SARS-CoV-2 induce a severe acute respiratory syndrome called COVID-19 and have led to more than six million deaths worldwide. Vaccination is the most effective preventative measure, and cellular and humoral immunity is crucial to developing individual protection. Here, we aim to...

Full description

Bibliographic Details
Main Authors: Tamiris Azamor, Ingrid Siciliano Horbach, Danielle Brito e Cunha, Juliana Gil Melgaço, Andréa Marques Vieira da Silva, Luciana Neves Tubarão, Adriana de Souza Azevedo, Renata Tourinho Santos, Nathalia dos Santos Alves, Thiago Lazari Machado, Jane Silva, Alessandro Fonseca de Souza, Camilla Bayma, Vanessa Pimenta Rocha, Ana Beatriz Teixeira Frederico, Brenda de Moura Dias, Bruno Pimenta Setatino, Caio Bidueira Denani, Samir Pereira da Costa Campos, Waleska Dias Schwarcz, Michel Vergne Sucupira, Edinea Pastro Mendes, Edimilson Domingos da Silva, Sheila Maria Barbosa de Lima, Ana Paula Dinis Ano Bom, Sotiris Missailidis
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
SARS-CoV-2 vaccine
ChAdOx1 nCoV-19
hybrid immunity
cellular and humoral immunity
Online Access:https://www.mdpi.com/1999-4915/14/9/1916

Internet

https://www.mdpi.com/1999-4915/14/9/1916

Similar Items